Our company
What We Do
Ferrosan Medical Devices develops and manufactures medical devices for haemostasis and biopsy procedures.
Haemostasis during surgery
-
Our gelatin-based haemostatic products are marketed globally under the SURGIFLO™, SPONGOSTAN™, and SURGIFOAM® trademarks through our long-standing partnership with Johnson & Johnson. These products play an important role in helping surgeons control bleeding during a wide range of surgical procedures. Johnson & Johnson is responsible for the global sales and distribution of the products in more than 100 countries, while we remain the legal manufacturer.
-
Electromechanical Devices
We have strong capabilities in electromechanical medical device development and manufacturing, with a focus on diagnostic biopsy sampling. We design, develop, and manufactures innovative, high-precision components and assemblies for leading global medical device companies. Together with ourpartner, we developed the world’s first handheld, tetherless single insertion device to collect multiple samples during a breast biopsy procedure. This is used by physicians to diagnose breast cancer. Today, we manufacture the second-generation biopsy device at our manufacturing site in Poland. We are a tier-one supplier to key partners, managing large parts – or the entirety – of their value chains, from design and industrialization to manufacturing and delivery. Our production is ISO 13485 certified and performed in controlled areas and cleanrooms in Szczecin, Poland.
How We Work
As an integrated innovation and manufacturing company, we combine clinical insight, research and development, quality management, and manufacturing excellence. Our capabilities span the entire value chain—from concept to commercial production. We are headquartered in Soeborg, Denmark, where our production, R&D, engineering, quality, and corporate functions are located. We also operate a manufacturing site in Szczecin, Poland. Together, we are about 512 dedicated employees working to deliver reliable, high-performing medical devices to healthcare professionals worldwide.
Our Legacy
A/S Ferrosan was founded in Copenhagen in 1920 by Niels Jacob Herman Weitzmann. We began with a simple yet ambitious mission: to improve people’s health through innovative healthcare solutions. The name Ferrosan, meaning “healthy iron,” reflected the early success with iron supplements such as Idozan and established a culture of research-driven innovation that continues today.
A defining milestone came in 1947 with the launch of SPONGOSTAN™, an absorbable gelatin haemostatic sponge developed through pioneering research into surgical bleeding control. This breakthrough marked the beginning of more than 75 years of expertise in haemostasis and laid the foundation for our position as a trusted partner to surgeons worldwide.
Over the following decades, we have expanded our haemostatic portfolio with milestones including the FDA approval of SURGIFOAM®, the introduction of the first SURGIFLO® haemostatic matrix, and continuous innovation in gelatin-based haemostatic technologies. A/S Ferrosan developed, produced, and sold prescription medicines, vitamin supplements, and hemostatic devices until 2010. To focus on hemostasis and medical devices, Ferrosan Medical Devices A/S was established that year, and the vitamin and pharmaceutical divisions were sold off. In 2011, we further strengthened our capabilities through the acquisition of Sonion Medical, expanding into minimally invasive surgical and breast biopsy devices.
Today, we serve healthcare professionals in more than 100 countries. Our legacy is defined by scientific excellence, manufacturing expertise, and a relentless commitment to manufacturing products that help clinicians improve patient outcomes around the world.
Our Ownership
Since 2022, Kirk Kapital, ATP, and the Lundbeck Foundation have been our owners, holding 40%, 30%, and 30% respectively.
Our People and Values
Our success depends on our people. We foster an environment where talent thrives, ideas grow, and collaboration drives innovation. We believe that by empowering creative, competent, and open-minded teams, we can continue to deliver products that make a difference when every second counts.
